Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic

Introduction

Horák and colleagues situate their study amid growing scientific and popular interest in ayahuasca, an Amazonian decoction typically prepared from Banisteriopsis caapi and Psychotria viridis (or alternative plants with comparable alkaloids). Earlier work has reported pharmacological actions relevant to mental health—beta-carbolines in B. caapi act as monoamine oxidase inhibitors and may promote neurogenesis, while DMT in P. viridis produces profound alterations of consciousness when protected from gut metabolism by MAO inhibition. Prior studies have suggested possible benefits in depression, addiction and other conditions, and ethnographic literature describes extensive ceremonial, religious and therapeutic uses; however, such findings leave open questions about how users in non‑Amazonian contexts understand and apply ayahuasca therapeutically. This paper aims to describe and interpret previously under‑reported practices of ayahuasca use in the Czech Republic, with particular attention to the therapeutic potential ascribed to it by local users. The investigators sought to map who takes part in rituals, what health problems users believe ayahuasca can treat, and the perceived mechanisms underlying any therapeutic effects, using qualitative interviews to generate theory grounded in participants’ accounts. The study therefore addresses a gap in knowledge about lay therapeutic narratives and practices in a European setting where DMT‑containing preparations are illegal.